

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 7.91927414 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 7.79728438 |
| 3 | regulation of platelet aggregation (GO:0090330) | 6.09329734 |
| 4 | definitive hemopoiesis (GO:0060216) | 6.02351853 |
| 5 | viral transcription (GO:0019083) | 6.00698430 |
| 6 | protein neddylation (GO:0045116) | 5.77614501 |
| 7 | translational termination (GO:0006415) | 5.74165819 |
| 8 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.67213553 |
| 9 | regulation of platelet activation (GO:0010543) | 5.50670951 |
| 10 | negative regulation of thymocyte apoptotic process (GO:0070244) | 5.23229390 |
| 11 | platelet aggregation (GO:0070527) | 5.21604589 |
| 12 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.20956149 |
| 13 | platelet dense granule organization (GO:0060155) | 5.12901739 |
| 14 | cotranslational protein targeting to membrane (GO:0006613) | 5.08607687 |
| 15 | translational elongation (GO:0006414) | 5.07510453 |
| 16 | protein targeting to ER (GO:0045047) | 5.06037592 |
| 17 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.03795887 |
| 18 | ribosomal small subunit biogenesis (GO:0042274) | 5.02496152 |
| 19 | adenosine receptor signaling pathway (GO:0001973) | 4.99944817 |
| 20 | positive regulation of mast cell activation (GO:0033005) | 4.98439994 |
| 21 | neutrophil activation (GO:0042119) | 4.96673815 |
| 22 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.90445487 |
| 23 | DNA strand elongation (GO:0022616) | 4.88755479 |
| 24 | megakaryocyte development (GO:0035855) | 4.88580410 |
| 25 | protein localization to endoplasmic reticulum (GO:0070972) | 4.83543564 |
| 26 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.83021406 |
| 27 | DNA deamination (GO:0045006) | 4.82085777 |
| 28 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.79281983 |
| 29 | lipoxygenase pathway (GO:0019372) | 4.77833014 |
| 30 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.73771557 |
| 31 | maturation of SSU-rRNA (GO:0030490) | 4.68759385 |
| 32 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.54038047 |
| 33 | viral life cycle (GO:0019058) | 4.52061499 |
| 34 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.50227016 |
| 35 | DNA replication initiation (GO:0006270) | 4.45141779 |
| 36 | granulocyte activation (GO:0036230) | 4.38194010 |
| 37 | angiogenesis involved in wound healing (GO:0060055) | 4.38100636 |
| 38 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.35516336 |
| 39 | cellular protein complex disassembly (GO:0043624) | 4.32873364 |
| 40 | negative regulation of platelet activation (GO:0010544) | 4.24337590 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.24164645 |
| 42 | negative regulation of norepinephrine secretion (GO:0010700) | 4.15094578 |
| 43 | thrombin receptor signaling pathway (GO:0070493) | 4.14212904 |
| 44 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.13066268 |
| 45 | DNA unwinding involved in DNA replication (GO:0006268) | 4.08397928 |
| 46 | telomere maintenance via recombination (GO:0000722) | 4.05226958 |
| 47 | response to interferon-beta (GO:0035456) | 4.04782405 |
| 48 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.01939659 |
| 49 | translational initiation (GO:0006413) | 4.01021561 |
| 50 | protein complex disassembly (GO:0043241) | 3.83823441 |
| 51 | regulation of integrin activation (GO:0033623) | 3.83816538 |
| 52 | homotypic cell-cell adhesion (GO:0034109) | 3.83571068 |
| 53 | negative regulation of heart rate (GO:0010459) | 3.83467109 |
| 54 | mitotic recombination (GO:0006312) | 3.82174259 |
| 55 | positive regulation of macrophage differentiation (GO:0045651) | 3.81207662 |
| 56 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.80925113 |
| 57 | platelet degranulation (GO:0002576) | 3.80488913 |
| 58 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.67144241 |
| 59 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.67010866 |
| 60 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.63156347 |
| 61 | platelet formation (GO:0030220) | 3.62379056 |
| 62 | heparin biosynthetic process (GO:0030210) | 3.61864909 |
| 63 | heparin metabolic process (GO:0030202) | 3.61864909 |
| 64 | regulation of mast cell degranulation (GO:0043304) | 3.61762892 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.60352386 |
| 66 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.60289452 |
| 67 | negative regulation of T cell apoptotic process (GO:0070233) | 3.59100181 |
| 68 | leukocyte degranulation (GO:0043299) | 3.58953787 |
| 69 | macromolecular complex disassembly (GO:0032984) | 3.58595659 |
| 70 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57858017 |
| 71 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57858017 |
| 72 | regulation of mast cell activation (GO:0033003) | 3.57321372 |
| 73 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.56638779 |
| 74 | endosome to pigment granule transport (GO:0043485) | 3.56558650 |
| 75 | endosome to melanosome transport (GO:0035646) | 3.56558650 |
| 76 | polyamine biosynthetic process (GO:0006596) | 3.53727634 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 3.53262871 |
| 78 | telomere maintenance via telomere lengthening (GO:0010833) | 3.52657025 |
| 79 | * platelet activation (GO:0030168) | 3.46444033 |
| 80 | low-density lipoprotein particle remodeling (GO:0034374) | 3.45065989 |
| 81 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.42441085 |
| 82 | secretory granule organization (GO:0033363) | 3.42305238 |
| 83 | purinergic receptor signaling pathway (GO:0035587) | 3.40925982 |
| 84 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.40676234 |
| 85 | purine-containing compound salvage (GO:0043101) | 3.40063740 |
| 86 | mRNA catabolic process (GO:0006402) | 3.39796345 |
| 87 | positive regulation of blood coagulation (GO:0030194) | 3.36072419 |
| 88 | positive regulation of hemostasis (GO:1900048) | 3.36072419 |
| 89 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.35631897 |
| 90 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.34879858 |
| 91 | protein targeting to membrane (GO:0006612) | 3.30799242 |
| 92 | mature B cell differentiation involved in immune response (GO:0002313) | 3.28945162 |
| 93 | CENP-A containing nucleosome assembly (GO:0034080) | 3.27525239 |
| 94 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.27248186 |
| 95 | positive regulation of mast cell degranulation (GO:0043306) | 3.27248186 |
| 96 | regulation of lipoprotein metabolic process (GO:0050746) | 3.26462459 |
| 97 | regulation of erythrocyte differentiation (GO:0045646) | 3.25742413 |
| 98 | response to interferon-alpha (GO:0035455) | 3.25240577 |
| 99 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.21624180 |
| 100 | RNA catabolic process (GO:0006401) | 3.21584234 |
| 101 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.21044137 |
| 102 | embryonic hemopoiesis (GO:0035162) | 3.20435434 |
| 103 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.17941616 |
| 104 | positive regulation of receptor recycling (GO:0001921) | 3.17639483 |
| 105 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.17480530 |
| 106 | * blood coagulation, intrinsic pathway (GO:0007597) | 3.15908484 |
| 107 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.14464430 |
| 108 | negative regulation of stress fiber assembly (GO:0051497) | 3.13938234 |
| 109 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.13144711 |
| 110 | termination of signal transduction (GO:0023021) | 3.11903586 |
| 111 | erythrocyte maturation (GO:0043249) | 3.11644529 |
| 112 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.08697120 |
| 113 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.07830043 |
| 114 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.07002017 |
| 115 | myeloid cell activation involved in immune response (GO:0002275) | 3.06459670 |
| 116 | heme biosynthetic process (GO:0006783) | 3.05840605 |
| 117 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.02696375 |
| 118 | positive regulation of coagulation (GO:0050820) | 3.01066347 |
| 119 | negative regulation of response to food (GO:0032096) | 3.00612051 |
| 120 | negative regulation of appetite (GO:0032099) | 3.00612051 |
| 121 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.00099625 |
| 122 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.00099625 |
| 123 | regulation of endothelial cell differentiation (GO:0045601) | 2.99487165 |
| 124 | translation (GO:0006412) | 2.98699207 |
| 125 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.98123895 |
| 126 | chromatin remodeling at centromere (GO:0031055) | 2.97338682 |
| 127 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.96768405 |
| 128 | pseudouridine synthesis (GO:0001522) | 2.96436963 |
| 129 | ribosomal large subunit biogenesis (GO:0042273) | 2.96225685 |
| 130 | histamine transport (GO:0051608) | 2.95054157 |
| 131 | regulation of thymocyte apoptotic process (GO:0070243) | 2.94505347 |
| 132 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.93505904 |
| 133 | mitochondrial calcium ion transport (GO:0006851) | 2.92757832 |
| 134 | autophagic vacuole fusion (GO:0000046) | 2.92141654 |
| 135 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.91223668 |
| 136 | phagocytosis, engulfment (GO:0006911) | 2.91162068 |
| 137 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.90746708 |
| 138 | DNA replication checkpoint (GO:0000076) | 2.90209193 |
| 139 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89861624 |
| 140 | negative regulation of cell killing (GO:0031342) | 2.89861624 |
| 141 | metallo-sulfur cluster assembly (GO:0031163) | 2.88880474 |
| 142 | iron-sulfur cluster assembly (GO:0016226) | 2.88880474 |
| 143 | beta-amyloid metabolic process (GO:0050435) | 2.88201972 |
| 144 | negative regulation of protein localization to cell surface (GO:2000009) | 2.87277284 |
| 145 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.87202923 |
| 146 | regulation of norepinephrine secretion (GO:0014061) | 2.86952902 |
| 147 | positive regulation of granulocyte differentiation (GO:0030854) | 2.86532939 |
| 148 | myeloid cell development (GO:0061515) | 2.85349171 |
| 149 | extracellular fibril organization (GO:0043206) | 2.83326792 |
| 150 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.82629448 |
| 151 | negative regulation of viral entry into host cell (GO:0046597) | 2.82622434 |
| 152 | regulation of leukocyte degranulation (GO:0043300) | 2.81593459 |
| 153 | positive regulation of respiratory burst (GO:0060267) | 2.80068254 |
| 154 | superoxide anion generation (GO:0042554) | 2.80028883 |
| 155 | regulation of regulatory T cell differentiation (GO:0045589) | 2.78971703 |
| 156 | regulation of cholesterol efflux (GO:0010874) | 2.78342239 |
| 157 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.77328450 |
| 158 | positive regulation of B cell mediated immunity (GO:0002714) | 2.77328450 |
| 159 | vesicle targeting (GO:0006903) | 2.76492315 |
| 160 | DNA replication-independent nucleosome organization (GO:0034724) | 2.76280168 |
| 161 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.76280168 |
| 162 | negative regulation of heart contraction (GO:0045822) | 2.75505431 |
| 163 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.75177386 |
| 164 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.74762537 |
| 165 | necroptotic process (GO:0070266) | 2.72583456 |
| 166 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.72184220 |
| 167 | microglial cell activation (GO:0001774) | 2.71915888 |
| 168 | T cell homeostasis (GO:0043029) | 2.69938396 |
| 169 | negative regulation of viral genome replication (GO:0045071) | 2.69293270 |
| 170 | oxygen transport (GO:0015671) | 2.67761603 |
| 171 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.67732797 |
| 172 | actin filament polymerization (GO:0030041) | 2.67399506 |
| 173 | IMP biosynthetic process (GO:0006188) | 2.67320576 |
| 174 | regulation of blood coagulation (GO:0030193) | 2.65543730 |
| 175 | L-fucose catabolic process (GO:0042355) | 2.65154811 |
| 176 | fucose catabolic process (GO:0019317) | 2.65154811 |
| 177 | L-fucose metabolic process (GO:0042354) | 2.65154811 |
| 178 | daunorubicin metabolic process (GO:0044597) | 2.64400753 |
| 179 | polyketide metabolic process (GO:0030638) | 2.64400753 |
| 180 | doxorubicin metabolic process (GO:0044598) | 2.64400753 |
| 181 | protein localization to kinetochore (GO:0034501) | 2.63186990 |
| 182 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.62282038 |
| 183 | mast cell activation (GO:0045576) | 2.61921702 |
| 184 | meiotic chromosome segregation (GO:0045132) | 2.61136984 |
| 185 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.57452186 |
| 186 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.56488613 |
| 187 | IMP metabolic process (GO:0046040) | 2.56336995 |
| 188 | histone mRNA metabolic process (GO:0008334) | 2.56173068 |
| 189 | telomere organization (GO:0032200) | 2.55347334 |
| 190 | telomere maintenance (GO:0000723) | 2.54338212 |
| 191 | heme metabolic process (GO:0042168) | 2.53876246 |
| 192 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.53495750 |
| 193 | Peyers patch development (GO:0048541) | 2.53495750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.51019105 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.64089699 |
| 3 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.57704007 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.92851358 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.21979319 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.06728927 |
| 7 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.06655513 |
| 8 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.97314584 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.89509543 |
| 10 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.88074617 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.72026278 |
| 12 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.71226688 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.70354559 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.65080756 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.60375535 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.55916087 |
| 17 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.53556275 |
| 18 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49239781 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.45224595 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.31634765 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.30136492 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26085601 |
| 23 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.24725493 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.23783739 |
| 25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.21519443 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.19927575 |
| 27 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.18440791 |
| 28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.14759307 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.14380934 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.13693677 |
| 31 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.12331932 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.10857547 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 2.10305882 |
| 34 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.08028686 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.01325047 |
| 36 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.00694307 |
| 37 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.97014741 |
| 38 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.90995528 |
| 39 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.90843057 |
| 40 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.88533477 |
| 41 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87576839 |
| 42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.87218810 |
| 43 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.86769346 |
| 44 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.86647420 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.85438617 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.84819137 |
| 47 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.84682458 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.81737398 |
| 49 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.81386217 |
| 50 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.80911224 |
| 51 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.78816507 |
| 52 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.76136347 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.72343344 |
| 54 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.71203369 |
| 55 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.71097501 |
| 56 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69257557 |
| 57 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.69064330 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65337303 |
| 59 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.61490272 |
| 60 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.60974409 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58521600 |
| 62 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56724020 |
| 63 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.55387233 |
| 64 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.55364175 |
| 65 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.54938826 |
| 66 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.50872740 |
| 67 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.50025548 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.49020888 |
| 69 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.48723097 |
| 70 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48683993 |
| 71 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43641157 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.43586460 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43343148 |
| 74 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.41901307 |
| 75 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40980094 |
| 76 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.38827922 |
| 77 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37557925 |
| 78 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.37249453 |
| 79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37137093 |
| 80 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.36422924 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.33948024 |
| 82 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.32824343 |
| 83 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.32326974 |
| 84 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.30238657 |
| 85 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29687317 |
| 86 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.29029999 |
| 87 | MAF_26560356_Chip-Seq_TH1_Human | 1.27719289 |
| 88 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.27627265 |
| 89 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.27609030 |
| 90 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27277807 |
| 91 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.27087395 |
| 92 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26971828 |
| 93 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.26398103 |
| 94 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.26315874 |
| 95 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.25617452 |
| 96 | MYB_26560356_Chip-Seq_TH2_Human | 1.23857723 |
| 97 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.22971229 |
| 98 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22343207 |
| 99 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20311331 |
| 100 | MYB_26560356_Chip-Seq_TH1_Human | 1.19930639 |
| 101 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19304547 |
| 102 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18804884 |
| 103 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18191875 |
| 104 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17293795 |
| 105 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.17019181 |
| 106 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16538084 |
| 107 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15158339 |
| 108 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.12007231 |
| 109 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11212321 |
| 110 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08880722 |
| 111 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07090452 |
| 112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06781318 |
| 113 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.06497894 |
| 114 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.06062085 |
| 115 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05662833 |
| 116 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.04205984 |
| 117 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01461868 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01293198 |
| 119 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01075235 |
| 120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00607207 |
| 121 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99086862 |
| 122 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98440653 |
| 123 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97884776 |
| 124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97071885 |
| 125 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96817650 |
| 126 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95797434 |
| 127 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95476316 |
| 128 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.94029225 |
| 129 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93172734 |
| 130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93078773 |
| 131 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92913794 |
| 132 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92904771 |
| 133 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92712828 |
| 134 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92622853 |
| 135 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.92548609 |
| 136 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91920368 |
| 137 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.89664045 |
| 138 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.88817587 |
| 139 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87884717 |
| 140 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.87235550 |
| 141 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.87147042 |
| 142 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86280947 |
| 143 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.86076055 |
| 144 | SPI1_23127762_ChIP-Seq_K562_Human | 0.86055461 |
| 145 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85836703 |
| 146 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85773449 |
| 147 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.85146284 |
| 148 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83451246 |
| 149 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83442013 |
| 150 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83399276 |
| 151 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82386792 |
| 152 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81147055 |
| 153 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78600836 |
| 154 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78600836 |
| 155 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.77736819 |
| 156 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77387334 |
| 157 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.74206124 |
| 158 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73121054 |
| 159 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71885594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008004_abnormal_stomach_pH | 4.70042180 |
| 2 | MP0002396_abnormal_hematopoietic_system | 4.25463982 |
| 3 | MP0005464_abnormal_platelet_physiology | 4.09310582 |
| 4 | MP0004147_increased_porphyrin_level | 4.03116631 |
| 5 | MP0004808_abnormal_hematopoietic_stem | 3.40092059 |
| 6 | MP0000465_gastrointestinal_hemorrhage | 3.32121081 |
| 7 | MP0003303_peritoneal_inflammation | 3.08253220 |
| 8 | MP0006054_spinal_hemorrhage | 3.05934496 |
| 9 | MP0003656_abnormal_erythrocyte_physiolo | 3.02161288 |
| 10 | MP0010094_abnormal_chromosome_stability | 2.94504820 |
| 11 | MP0004510_myositis | 2.93487538 |
| 12 | MP0001545_abnormal_hematopoietic_system | 2.63435266 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 2.63435266 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.48032493 |
| 15 | MP0003724_increased_susceptibility_to | 2.46301890 |
| 16 | MP0005671_abnormal_response_to | 2.28150324 |
| 17 | MP0005174_abnormal_tail_pigmentation | 2.25752323 |
| 18 | MP0000490_abnormal_crypts_of | 2.19721166 |
| 19 | MP0003693_abnormal_embryo_hatching | 2.19142076 |
| 20 | MP0002398_abnormal_bone_marrow | 2.17181815 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.13054046 |
| 22 | MP0008058_abnormal_DNA_repair | 2.12806291 |
| 23 | MP0005075_abnormal_melanosome_morpholog | 2.12756311 |
| 24 | MP0009785_altered_susceptibility_to | 2.10074100 |
| 25 | MP0009379_abnormal_foot_pigmentation | 2.06753260 |
| 26 | MP0000685_abnormal_immune_system | 2.02224467 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.94392935 |
| 28 | MP0003111_abnormal_nucleus_morphology | 1.94334182 |
| 29 | MP0003077_abnormal_cell_cycle | 1.94021876 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.89149065 |
| 31 | MP0008057_abnormal_DNA_replication | 1.87447050 |
| 32 | MP0001851_eye_inflammation | 1.84528383 |
| 33 | MP0002722_abnormal_immune_system | 1.83689871 |
| 34 | MP0002095_abnormal_skin_pigmentation | 1.83127793 |
| 35 | MP0008007_abnormal_cellular_replicative | 1.78430180 |
| 36 | MP0006036_abnormal_mitochondrial_physio | 1.75319991 |
| 37 | MP0002429_abnormal_blood_cell | 1.74965210 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.70512912 |
| 39 | MP0005025_abnormal_response_to | 1.68347378 |
| 40 | MP0000230_abnormal_systemic_arterial | 1.64814504 |
| 41 | MP0001800_abnormal_humoral_immune | 1.63633732 |
| 42 | MP0001853_heart_inflammation | 1.62733211 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.61254346 |
| 44 | MP0004947_skin_inflammation | 1.61047055 |
| 45 | MP0004957_abnormal_blastocyst_morpholog | 1.60398573 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.59643081 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.58906211 |
| 48 | MP0001819_abnormal_immune_cell | 1.57377464 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.57044170 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.56941775 |
| 51 | MP0000716_abnormal_immune_system | 1.56546651 |
| 52 | MP0003866_abnormal_defecation | 1.55669380 |
| 53 | MP0002736_abnormal_nociception_after | 1.54947607 |
| 54 | MP0002723_abnormal_immune_serum | 1.54840300 |
| 55 | MP0004084_abnormal_cardiac_muscle | 1.52035365 |
| 56 | MP0003943_abnormal_hepatobiliary_system | 1.45914153 |
| 57 | MP0003879_abnormal_hair_cell | 1.45456740 |
| 58 | MP0005000_abnormal_immune_tolerance | 1.44957964 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.44029248 |
| 60 | MP0001663_abnormal_digestive_system | 1.39501408 |
| 61 | MP0004130_abnormal_muscle_cell | 1.38392042 |
| 62 | MP0000343_altered_response_to | 1.36637566 |
| 63 | MP0009697_abnormal_copulation | 1.33509867 |
| 64 | MP0010368_abnormal_lymphatic_system | 1.30780997 |
| 65 | MP0000858_altered_metastatic_potential | 1.30481986 |
| 66 | MP0002877_abnormal_melanocyte_morpholog | 1.28675435 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.28597647 |
| 68 | MP0002419_abnormal_innate_immunity | 1.27662546 |
| 69 | MP0000249_abnormal_blood_vessel | 1.24939110 |
| 70 | MP0001873_stomach_inflammation | 1.24822486 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.24193739 |
| 72 | MP0003436_decreased_susceptibility_to | 1.23227367 |
| 73 | MP0002019_abnormal_tumor_incidence | 1.22369638 |
| 74 | MP0008775_abnormal_heart_ventricle | 1.21338663 |
| 75 | MP0003186_abnormal_redox_activity | 1.20491868 |
| 76 | MP0004036_abnormal_muscle_relaxation | 1.17007829 |
| 77 | MP0000313_abnormal_cell_death | 1.15807259 |
| 78 | MP0005410_abnormal_fertilization | 1.15160272 |
| 79 | MP0008872_abnormal_physiological_respon | 1.13381007 |
| 80 | MP0002405_respiratory_system_inflammati | 1.13174709 |
| 81 | MP0003567_abnormal_fetal_cardiomyocyte | 1.10525183 |
| 82 | MP0009278_abnormal_bone_marrow | 1.06399294 |
| 83 | MP0008469_abnormal_protein_level | 1.05073728 |
| 84 | MP0000015_abnormal_ear_pigmentation | 1.04236695 |
| 85 | MP0001968_abnormal_touch/_nociception | 1.03475578 |
| 86 | MP0001845_abnormal_inflammatory_respons | 1.03351819 |
| 87 | MP0006292_abnormal_olfactory_placode | 1.01047491 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.99969026 |
| 89 | MP0008874_decreased_physiological_sensi | 0.99900876 |
| 90 | MP0001790_abnormal_immune_system | 0.98904503 |
| 91 | MP0005387_immune_system_phenotype | 0.98904503 |
| 92 | MP0006082_CNS_inflammation | 0.98891276 |
| 93 | MP0005083_abnormal_biliary_tract | 0.97253275 |
| 94 | MP0002006_tumorigenesis | 0.96474746 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.96343225 |
| 96 | MP0003075_altered_response_to | 0.95804785 |
| 97 | MP0001879_abnormal_lymphatic_vessel | 0.94571120 |
| 98 | MP0008260_abnormal_autophagy | 0.93002079 |
| 99 | MP0002733_abnormal_thermal_nociception | 0.92831810 |
| 100 | MP0008877_abnormal_DNA_methylation | 0.92824149 |
| 101 | MP0002132_abnormal_respiratory_system | 0.89832785 |
| 102 | MP0009642_abnormal_blood_homeostasis | 0.88557819 |
| 103 | MP0010329_abnormal_lipoprotein_level | 0.87120606 |
| 104 | MP0005381_digestive/alimentary_phenotyp | 0.85958648 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.83839451 |
| 106 | MP0000598_abnormal_liver_morphology | 0.80273195 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.78645865 |
| 108 | MP0005165_increased_susceptibility_to | 0.78547516 |
| 109 | MP0001764_abnormal_homeostasis | 0.77975319 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.77946667 |
| 111 | MP0003183_abnormal_peptide_metabolism | 0.76511961 |
| 112 | MP0004883_abnormal_blood_vessel | 0.76302699 |
| 113 | MP0009763_increased_sensitivity_to | 0.73160927 |
| 114 | MP0005646_abnormal_pituitary_gland | 0.72771734 |
| 115 | MP0005535_abnormal_body_temperature | 0.71642347 |
| 116 | MP0003453_abnormal_keratinocyte_physiol | 0.71445592 |
| 117 | MP0000350_abnormal_cell_proliferation | 0.70744412 |
| 118 | MP0003828_pulmonary_edema | 0.70057976 |
| 119 | MP0005310_abnormal_salivary_gland | 0.69807425 |
| 120 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69804985 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.69408172 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.69003274 |
| 123 | MP0001915_intracranial_hemorrhage | 0.68942430 |
| 124 | MP0001765_abnormal_ion_homeostasis | 0.68521734 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.67738126 |
| 126 | MP0004484_altered_response_of | 0.67522129 |
| 127 | MP0008932_abnormal_embryonic_tissue | 0.67381668 |
| 128 | MP0003868_abnormal_feces_composition | 0.67115846 |
| 129 | MP0005023_abnormal_wound_healing | 0.66446894 |
| 130 | MP0002653_abnormal_ependyma_morphology | 0.65390586 |
| 131 | MP0003638_abnormal_response/metabolism_ | 0.65378844 |
| 132 | MP0005409_darkened_coat_color | 0.65223344 |
| 133 | MP0001970_abnormal_pain_threshold | 0.64618542 |
| 134 | MP0000477_abnormal_intestine_morphology | 0.64385487 |
| 135 | MP0009764_decreased_sensitivity_to | 0.63822509 |
| 136 | MP0003795_abnormal_bone_structure | 0.63153920 |
| 137 | MP0001544_abnormal_cardiovascular_syste | 0.60900224 |
| 138 | MP0005385_cardiovascular_system_phenoty | 0.60900224 |
| 139 | MP0008873_increased_physiological_sensi | 0.60870408 |
| 140 | MP0001348_abnormal_lacrimal_gland | 0.60230881 |
| 141 | MP0002128_abnormal_blood_circulation | 0.60034626 |
| 142 | MP0003786_premature_aging | 0.58904571 |
| 143 | MP0002118_abnormal_lipid_homeostasis | 0.57844152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 7.03900476 |
| 2 | * Prolonged bleeding time (HP:0003010) | 6.31400581 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 6.19656299 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.08081619 |
| 5 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 6.01938301 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 5.78923065 |
| 7 | Aplastic anemia (HP:0001915) | 5.08841443 |
| 8 | Impaired platelet aggregation (HP:0003540) | 5.01291851 |
| 9 | Abnormal platelet function (HP:0011869) | 5.01291851 |
| 10 | Thrombocytosis (HP:0001894) | 4.94323962 |
| 11 | Reticulocytopenia (HP:0001896) | 4.76086384 |
| 12 | * Purpura (HP:0000979) | 4.58956657 |
| 13 | * Epistaxis (HP:0000421) | 4.23421476 |
| 14 | IgM deficiency (HP:0002850) | 4.12379363 |
| 15 | Chronic otitis media (HP:0000389) | 3.92176375 |
| 16 | Pallor (HP:0000980) | 3.72363209 |
| 17 | Gingival bleeding (HP:0000225) | 3.69909367 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.66832417 |
| 19 | Stomatitis (HP:0010280) | 3.61692299 |
| 20 | Conjunctival telangiectasia (HP:0000524) | 3.58555338 |
| 21 | Muscle fiber atrophy (HP:0100295) | 3.49028692 |
| 22 | * Abnormal platelet volume (HP:0011876) | 3.47488050 |
| 23 | Type 2 muscle fiber atrophy (HP:0003554) | 3.46023295 |
| 24 | * Menorrhagia (HP:0000132) | 3.33548794 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.30699017 |
| 26 | Increased density of long bones (HP:0006392) | 3.27719931 |
| 27 | Dyschromatopsia (HP:0007641) | 3.23476132 |
| 28 | Macrocytic anemia (HP:0001972) | 3.18421160 |
| 29 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.16917714 |
| 30 | * Increased mean platelet volume (HP:0011877) | 3.13814265 |
| 31 | Poikilocytosis (HP:0004447) | 3.11997618 |
| 32 | Type I transferrin isoform profile (HP:0003642) | 3.11411147 |
| 33 | Obstructive lung disease (HP:0006536) | 3.09751002 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.09751002 |
| 35 | Eczematoid dermatitis (HP:0000976) | 3.05398871 |
| 36 | Abnormal pupillary function (HP:0007686) | 3.04169782 |
| 37 | Amaurosis fugax (HP:0100576) | 2.91247947 |
| 38 | Hepatosplenomegaly (HP:0001433) | 2.91144843 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.84432451 |
| 40 | Increased IgM level (HP:0003496) | 2.81860176 |
| 41 | Paralysis (HP:0003470) | 2.79238504 |
| 42 | Microcytic anemia (HP:0001935) | 2.78581660 |
| 43 | Reduced antithrombin III activity (HP:0001976) | 2.77125380 |
| 44 | Myelodysplasia (HP:0002863) | 2.75386432 |
| 45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.73057759 |
| 46 | Abnormality of the prostate (HP:0008775) | 2.72368836 |
| 47 | Encephalitis (HP:0002383) | 2.69633243 |
| 48 | Papilledema (HP:0001085) | 2.62725844 |
| 49 | Pancytopenia (HP:0001876) | 2.58749900 |
| 50 | Recurrent viral infections (HP:0004429) | 2.55802891 |
| 51 | Episodic fever (HP:0001954) | 2.55291652 |
| 52 | 11 pairs of ribs (HP:0000878) | 2.54360945 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.54330308 |
| 54 | Hepatocellular necrosis (HP:0001404) | 2.49468486 |
| 55 | Abnormality of reticulocytes (HP:0004312) | 2.47938564 |
| 56 | Myositis (HP:0100614) | 2.46007760 |
| 57 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.45106190 |
| 58 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.43353585 |
| 59 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.43353585 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.41954126 |
| 61 | Joint swelling (HP:0001386) | 2.41684309 |
| 62 | Hyperthyroidism (HP:0000836) | 2.41388079 |
| 63 | Polycythemia (HP:0001901) | 2.40041532 |
| 64 | Abnormal glycosylation (HP:0012345) | 2.39358192 |
| 65 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.39358192 |
| 66 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.39358192 |
| 67 | Abnormal protein glycosylation (HP:0012346) | 2.39358192 |
| 68 | Increased intramyocellular lipid droplets (HP:0012240) | 2.37243471 |
| 69 | Bruising susceptibility (HP:0000978) | 2.35058756 |
| 70 | Colon cancer (HP:0003003) | 2.34475967 |
| 71 | Recurrent bacterial skin infections (HP:0005406) | 2.33991398 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.32611475 |
| 73 | Hepatic necrosis (HP:0002605) | 2.32079739 |
| 74 | Cellulitis (HP:0100658) | 2.32053266 |
| 75 | Ventricular fibrillation (HP:0001663) | 2.31094634 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 2.30606830 |
| 77 | Xanthomatosis (HP:0000991) | 2.28077635 |
| 78 | Panhypogammaglobulinemia (HP:0003139) | 2.27928553 |
| 79 | Asplenia (HP:0001746) | 2.26861993 |
| 80 | Oral leukoplakia (HP:0002745) | 2.23973267 |
| 81 | Increased serum ferritin (HP:0003281) | 2.22787924 |
| 82 | Lymphoma (HP:0002665) | 2.19600247 |
| 83 | Increased cerebral lipofuscin (HP:0011813) | 2.19375842 |
| 84 | Joint hemorrhage (HP:0005261) | 2.18072701 |
| 85 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.16687924 |
| 86 | Arterial thrombosis (HP:0004420) | 2.16442596 |
| 87 | Birth length less than 3rd percentile (HP:0003561) | 2.15289237 |
| 88 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.15211613 |
| 89 | Acanthocytosis (HP:0001927) | 2.13079598 |
| 90 | Recurrent bronchitis (HP:0002837) | 2.10641407 |
| 91 | Tinnitus (HP:0000360) | 2.08789705 |
| 92 | Increased muscle lipid content (HP:0009058) | 2.06322463 |
| 93 | Abnormality of lateral ventricle (HP:0030047) | 2.03711008 |
| 94 | Microvesicular hepatic steatosis (HP:0001414) | 2.03449528 |
| 95 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.02787369 |
| 96 | Albinism (HP:0001022) | 2.02533697 |
| 97 | Agnosia (HP:0010524) | 2.00283787 |
| 98 | Chest pain (HP:0100749) | 2.00062298 |
| 99 | Acute myeloid leukemia (HP:0004808) | 1.99994699 |
| 100 | Basal cell carcinoma (HP:0002671) | 1.99099574 |
| 101 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.97941315 |
| 102 | Gastrointestinal inflammation (HP:0004386) | 1.97238748 |
| 103 | Intestinal atresia (HP:0011100) | 1.95976941 |
| 104 | Dysautonomia (HP:0002459) | 1.92404878 |
| 105 | Hyperbilirubinemia (HP:0002904) | 1.89576051 |
| 106 | Leukocytosis (HP:0001974) | 1.88745535 |
| 107 | Vertigo (HP:0002321) | 1.87605067 |
| 108 | Decreased central vision (HP:0007663) | 1.87459863 |
| 109 | Migraine (HP:0002076) | 1.86352850 |
| 110 | Abnormal auditory evoked potentials (HP:0006958) | 1.86138309 |
| 111 | Exertional dyspnea (HP:0002875) | 1.85636381 |
| 112 | Neutropenia (HP:0001875) | 1.84935420 |
| 113 | Abnormality of T cells (HP:0002843) | 1.84589873 |
| 114 | Diplopia (HP:0000651) | 1.84247589 |
| 115 | Abnormality of binocular vision (HP:0011514) | 1.84247589 |
| 116 | Bone marrow hypocellularity (HP:0005528) | 1.83672007 |
| 117 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.83530944 |
| 118 | Nausea (HP:0002018) | 1.82530677 |
| 119 | Abnormality of the nasal mucosa (HP:0000433) | 1.82084001 |
| 120 | Poikiloderma (HP:0001029) | 1.81681409 |
| 121 | Erythema (HP:0010783) | 1.81388752 |
| 122 | Agammaglobulinemia (HP:0004432) | 1.80291488 |
| 123 | Increased hepatocellular lipid droplets (HP:0006565) | 1.79793651 |
| 124 | IgG deficiency (HP:0004315) | 1.78225327 |
| 125 | Inflammation of the large intestine (HP:0002037) | 1.77533502 |
| 126 | Acute lymphatic leukemia (HP:0006721) | 1.77467550 |
| 127 | Hypochromic anemia (HP:0001931) | 1.76934147 |
| 128 | Microretrognathia (HP:0000308) | 1.76223208 |
| 129 | Male infertility (HP:0003251) | 1.76197562 |
| 130 | Granulocytopenia (HP:0001913) | 1.75319000 |
| 131 | Myocardial infarction (HP:0001658) | 1.74995532 |
| 132 | Upper limb muscle weakness (HP:0003484) | 1.74815750 |
| 133 | Nonprogressive disorder (HP:0003680) | 1.74001149 |
| 134 | Congenital, generalized hypertrichosis (HP:0004540) | 1.71621167 |
| 135 | Autoimmune hemolytic anemia (HP:0001890) | 1.71455289 |
| 136 | Abnormality of iron homeostasis (HP:0011031) | 1.69191840 |
| 137 | Easy fatigability (HP:0003388) | 1.68088464 |
| 138 | Generalized aminoaciduria (HP:0002909) | 1.67917291 |
| 139 | Papillary thyroid carcinoma (HP:0002895) | 1.67900938 |
| 140 | Lymphopenia (HP:0001888) | 1.67747041 |
| 141 | Distal lower limb amyotrophy (HP:0008944) | 1.66834360 |
| 142 | Increased serum lactate (HP:0002151) | 1.65360552 |
| 143 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.64838036 |
| 144 | Spontaneous hematomas (HP:0007420) | 1.63416012 |
| 145 | 3-Methylglutaconic aciduria (HP:0003535) | 1.63335512 |
| 146 | Thrombophlebitis (HP:0004418) | 1.63324062 |
| 147 | Dysostosis multiplex (HP:0000943) | 1.62986613 |
| 148 | Abnormal hemoglobin (HP:0011902) | 1.62953215 |
| 149 | Basal ganglia calcification (HP:0002135) | 1.62935765 |
| 150 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.62517693 |
| 151 | Pulmonary embolism (HP:0002204) | 1.61803531 |
| 152 | Meningitis (HP:0001287) | 1.59870507 |
| 153 | Spontaneous abortion (HP:0005268) | 1.59093217 |
| 154 | Hypertriglyceridemia (HP:0002155) | 1.58888860 |
| 155 | Retrobulbar optic neuritis (HP:0100654) | 1.57597038 |
| 156 | Optic neuritis (HP:0100653) | 1.57597038 |
| 157 | Recurrent fungal infections (HP:0002841) | 1.55658919 |
| 158 | Orchitis (HP:0100796) | 1.55160634 |
| 159 | Vasculitis (HP:0002633) | 1.54307833 |
| 160 | Cerebral ischemia (HP:0002637) | 1.50860994 |
| 161 | Eosinophilia (HP:0001880) | 1.50701512 |
| 162 | Mucosal telangiectasiae (HP:0100579) | 1.50266988 |
| 163 | Gastrointestinal infarctions (HP:0005244) | 1.50073298 |
| 164 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.49201112 |
| 165 | Abnormal ciliary motility (HP:0012262) | 1.48428691 |
| 166 | Hemorrhage of the eye (HP:0011885) | 1.46845171 |
| 167 | Muscle fibrillation (HP:0010546) | 1.44857246 |
| 168 | Increased IgE level (HP:0003212) | 1.43790898 |
| 169 | Urticaria (HP:0001025) | 1.43139351 |
| 170 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.41007283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 6.30502728 |
| 2 | BMX | 3.88098922 |
| 3 | MST4 | 3.82042162 |
| 4 | STK16 | 3.04156414 |
| 5 | TIE1 | 2.92966183 |
| 6 | WEE1 | 2.79766602 |
| 7 | MAP4K1 | 2.76102365 |
| 8 | TGFBR1 | 2.59969176 |
| 9 | NME2 | 2.59649718 |
| 10 | GRK6 | 2.55322997 |
| 11 | CDK19 | 2.54644586 |
| 12 | CDC7 | 2.43902361 |
| 13 | PTK2B | 2.41604129 |
| 14 | KIT | 2.41350804 |
| 15 | CCNB1 | 2.23028779 |
| 16 | ACVR1B | 2.16629053 |
| 17 | VRK1 | 2.15538401 |
| 18 | TEC | 2.00048303 |
| 19 | MKNK1 | 1.98296257 |
| 20 | BTK | 1.97838007 |
| 21 | MAPKAPK5 | 1.96332060 |
| 22 | MAP2K3 | 1.93911023 |
| 23 | MUSK | 1.91187697 |
| 24 | FGR | 1.90141937 |
| 25 | BRSK2 | 1.86721784 |
| 26 | BMPR2 | 1.84523112 |
| 27 | PIM2 | 1.82992348 |
| 28 | GRK5 | 1.78663286 |
| 29 | NEK2 | 1.78661610 |
| 30 | HCK | 1.77358649 |
| 31 | TGFBR2 | 1.71926428 |
| 32 | CDK8 | 1.66548283 |
| 33 | MATK | 1.62937578 |
| 34 | DYRK3 | 1.61497548 |
| 35 | CAMKK2 | 1.61487498 |
| 36 | TXK | 1.59181653 |
| 37 | PIK3CG | 1.57910678 |
| 38 | KDR | 1.50078232 |
| 39 | TSSK6 | 1.49619001 |
| 40 | TAOK1 | 1.44975278 |
| 41 | EIF2AK1 | 1.43194425 |
| 42 | RPS6KB2 | 1.41927468 |
| 43 | CSK | 1.39964668 |
| 44 | JAK3 | 1.35164507 |
| 45 | ZAP70 | 1.30697117 |
| 46 | TAOK2 | 1.26825956 |
| 47 | MAP3K3 | 1.24578975 |
| 48 | SIK3 | 1.20786713 |
| 49 | PASK | 1.18517015 |
| 50 | BRSK1 | 1.17986360 |
| 51 | NEK1 | 1.14893926 |
| 52 | SYK | 1.14886981 |
| 53 | STK3 | 1.13712079 |
| 54 | TBK1 | 1.12971582 |
| 55 | STK24 | 1.12403720 |
| 56 | ERN1 | 1.11409317 |
| 57 | MAP3K6 | 1.08628802 |
| 58 | BCKDK | 1.08537280 |
| 59 | PAK1 | 1.08278644 |
| 60 | EEF2K | 1.06616710 |
| 61 | TYK2 | 1.02330081 |
| 62 | FLT3 | 1.01683805 |
| 63 | TAOK3 | 1.00843957 |
| 64 | CSF1R | 1.00354133 |
| 65 | LRRK2 | 0.99411591 |
| 66 | ATR | 0.99013445 |
| 67 | ITK | 0.98997801 |
| 68 | MAP3K12 | 0.98968781 |
| 69 | TLK1 | 0.98112395 |
| 70 | DAPK3 | 0.96258107 |
| 71 | CDK7 | 0.96189963 |
| 72 | MARK3 | 0.96184334 |
| 73 | DAPK1 | 0.96152206 |
| 74 | MAP3K5 | 0.93941794 |
| 75 | TNIK | 0.93282398 |
| 76 | LYN | 0.92993392 |
| 77 | SCYL2 | 0.91352108 |
| 78 | PIM1 | 0.89799897 |
| 79 | NEK9 | 0.89479404 |
| 80 | RPS6KA4 | 0.87133798 |
| 81 | AURKB | 0.86918290 |
| 82 | TESK2 | 0.86799964 |
| 83 | IKBKB | 0.85943783 |
| 84 | PDK1 | 0.85895331 |
| 85 | PKN2 | 0.83928904 |
| 86 | IRAK4 | 0.83452544 |
| 87 | BLK | 0.80563590 |
| 88 | EPHB1 | 0.79340597 |
| 89 | DAPK2 | 0.78965125 |
| 90 | RPS6KA5 | 0.78438712 |
| 91 | PDPK1 | 0.77710849 |
| 92 | BUB1 | 0.77595550 |
| 93 | IRAK1 | 0.76735291 |
| 94 | EIF2AK3 | 0.74119959 |
| 95 | ADRBK1 | 0.73107293 |
| 96 | RET | 0.69760050 |
| 97 | PAK4 | 0.68593367 |
| 98 | MAP2K6 | 0.68099445 |
| 99 | SRPK1 | 0.67706582 |
| 100 | JAK2 | 0.67535332 |
| 101 | EPHA3 | 0.67353829 |
| 102 | IKBKE | 0.64846960 |
| 103 | PIK3CA | 0.63156705 |
| 104 | STK4 | 0.62578048 |
| 105 | PLK2 | 0.62085421 |
| 106 | MAPKAPK3 | 0.61602396 |
| 107 | TNK2 | 0.61476439 |
| 108 | HIPK2 | 0.61409300 |
| 109 | PRKG2 | 0.60657332 |
| 110 | MAP3K1 | 0.59841767 |
| 111 | YES1 | 0.58802388 |
| 112 | FYN | 0.58421637 |
| 113 | PRKD1 | 0.58232441 |
| 114 | ERBB2 | 0.56532132 |
| 115 | PINK1 | 0.55992941 |
| 116 | PLK1 | 0.55150604 |
| 117 | PKN1 | 0.55077066 |
| 118 | ILK | 0.53424361 |
| 119 | ADRBK2 | 0.53362829 |
| 120 | CAMKK1 | 0.53280736 |
| 121 | MAP3K11 | 0.53053030 |
| 122 | JAK1 | 0.51844049 |
| 123 | LCK | 0.51133260 |
| 124 | PDGFRB | 0.51106541 |
| 125 | CLK1 | 0.50106449 |
| 126 | LMTK2 | 0.50011475 |
| 127 | PLK4 | 0.47351284 |
| 128 | CDK6 | 0.47145634 |
| 129 | PRKACG | 0.46812377 |
| 130 | CAMK1 | 0.46795420 |
| 131 | MAPK4 | 0.46228536 |
| 132 | MAPK11 | 0.45502169 |
| 133 | RAF1 | 0.44458190 |
| 134 | FES | 0.44269419 |
| 135 | DYRK1B | 0.44234032 |
| 136 | MAP3K8 | 0.42680702 |
| 137 | MAPK12 | 0.42306055 |
| 138 | RPS6KA6 | 0.41572075 |
| 139 | MAP2K1 | 0.41304937 |
| 140 | ZAK | 0.40426699 |
| 141 | CDK4 | 0.40039441 |
| 142 | MKNK2 | 0.39522887 |
| 143 | ARAF | 0.39050184 |
| 144 | MYLK | 0.38792949 |
| 145 | EPHB2 | 0.37946805 |
| 146 | MAPK15 | 0.37771483 |
| 147 | PRKCD | 0.37338555 |
| 148 | PRKCQ | 0.35923579 |
| 149 | IRAK2 | 0.35808675 |
| 150 | MAPK13 | 0.30753032 |
| 151 | FER | 0.30099910 |
| 152 | PRKG1 | 0.27861036 |
| 153 | TRIM28 | 0.27764113 |
| 154 | MARK2 | 0.24627886 |
| 155 | PRKCB | 0.22173834 |
| 156 | PNCK | 0.21524622 |
| 157 | SRC | 0.21243669 |
| 158 | SGK3 | 0.20769915 |
| 159 | PRKD2 | 0.20655772 |
| 160 | PRKCA | 0.20256137 |
| 161 | MINK1 | 0.18803060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.90637107 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 5.15613214 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 4.24564684 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.77708094 |
| 5 | Homologous recombination_Homo sapiens_hsa03440 | 2.90282197 |
| 6 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.60549661 |
| 7 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.53547740 |
| 8 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 2.13517076 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.13512250 |
| 10 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.03650653 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 1.99610063 |
| 12 | * Platelet activation_Homo sapiens_hsa04611 | 1.98324611 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 1.93464365 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.90639910 |
| 15 | Protein export_Homo sapiens_hsa03060 | 1.86553260 |
| 16 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.80830583 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.80212096 |
| 18 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76049023 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.62929166 |
| 20 | Gap junction_Homo sapiens_hsa04540 | 1.56763251 |
| 21 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.46936578 |
| 22 | RNA degradation_Homo sapiens_hsa03018 | 1.43407623 |
| 23 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.43372647 |
| 24 | Endocytosis_Homo sapiens_hsa04144 | 1.41390254 |
| 25 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.40696188 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.37768185 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.35493165 |
| 28 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.35290102 |
| 29 | Purine metabolism_Homo sapiens_hsa00230 | 1.34460159 |
| 30 | * ECM-receptor interaction_Homo sapiens_hsa04512 | 1.33568760 |
| 31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.33439932 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31559401 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.31150150 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30316897 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.29524088 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28902572 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.25637120 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24554636 |
| 39 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.23985413 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.22261650 |
| 41 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.17239293 |
| 42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.16020463 |
| 43 | RNA transport_Homo sapiens_hsa03013 | 1.14903734 |
| 44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.13831191 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.12902638 |
| 46 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.12859780 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.08470937 |
| 48 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.07420347 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07236543 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.07173689 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06145631 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.05499407 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04619373 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02661847 |
| 55 | Measles_Homo sapiens_hsa05162 | 0.99116371 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.97904335 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.97195258 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 0.96536873 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95388710 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95324051 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95020399 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.93695974 |
| 63 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.93215396 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.89348599 |
| 65 | Leishmaniasis_Homo sapiens_hsa05140 | 0.89250837 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88144838 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86716231 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.85514438 |
| 69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82843370 |
| 70 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.82398171 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81315503 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.81123189 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.78954095 |
| 74 | Olfactory transduction_Homo sapiens_hsa04740 | 0.78915086 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77090219 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76996981 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76636887 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76254377 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.73660770 |
| 80 | Focal adhesion_Homo sapiens_hsa04510 | 0.73415777 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.72887319 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72826689 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72441416 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.72384423 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72164745 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71241657 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70866693 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70492750 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66672960 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66483794 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.65412037 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64123434 |
| 93 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.63328027 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63269651 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61258040 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.61036220 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59875790 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59772307 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58821413 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58374921 |
| 101 | Parkinsons disease_Homo sapiens_hsa05012 | 0.58265000 |
| 102 | Circadian entrainment_Homo sapiens_hsa04713 | 0.57471836 |
| 103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57290103 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57287217 |
| 105 | Influenza A_Homo sapiens_hsa05164 | 0.57193499 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57147581 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56872981 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56384316 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56104573 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.55949972 |
| 111 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55816119 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.53795030 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53577162 |
| 114 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52958396 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51976697 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51581339 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49577520 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49321552 |
| 119 | Pertussis_Homo sapiens_hsa05133 | 0.48757882 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48110007 |
| 121 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48023448 |
| 122 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47086600 |
| 123 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46851206 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46445036 |
| 125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44694959 |
| 126 | Malaria_Homo sapiens_hsa05144 | 0.44175528 |
| 127 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.43827657 |
| 128 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43762899 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43494490 |
| 130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41408900 |
| 131 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40785493 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40783490 |
| 133 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40569514 |
| 134 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40540550 |
| 135 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.40391901 |
| 136 | Glioma_Homo sapiens_hsa05214 | 0.39109507 |
| 137 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38750507 |
| 138 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38510122 |
| 139 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.38438414 |
| 140 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.38206185 |
| 141 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37888892 |
| 142 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37876965 |
| 143 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37487404 |
| 144 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34083179 |
| 145 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33438898 |
| 146 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.32662914 |
| 147 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31150405 |
| 148 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.30033664 |
| 149 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27215244 |
| 150 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.26668568 |
| 151 | Huntingtons disease_Homo sapiens_hsa05016 | 0.25939187 |
| 152 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.25918551 |
| 153 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.25758658 |
| 154 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25047909 |
| 155 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.24227766 |
| 156 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.23394559 |
| 157 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23102004 |
| 158 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.22782067 |
| 159 | Salmonella infection_Homo sapiens_hsa05132 | 0.19628034 |
| 160 | ABC transporters_Homo sapiens_hsa02010 | 0.19148133 |
| 161 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.18944918 |

